Project Grant R21NS138720

Award Date 4/1/25
Completion Date 3/31/27
Dollars Obligated $245K
Federal Grant Program
93.853
Assistance Type
Project Grant
Place of Performance
Connecticut, USA
Similar Awards
This federal Project Grant award from the National Institute of Biomedical Imaging and Bioengineering (CFDA 93.286, Discovery and Applied Research for Technological Innovations to Improve Human Health) provides $1,085,020 to Yale University to develop an improved framework for assessing drug efficacy and target engagement using positron emission tomography (PET) imaging. The project aims to jointly estimate spatial receptor occupancy maps and a global half-maximum effective concentration...
The National Institutes of Health (NIH) awarded Yale University a $1,722,700 Project Grant under the Research Infrastructure Programs (CFDA 93.351) to acquire a state-of-the-art preclinical Positron Emission Tomography (PET)/Computed Tomography (CT) imaging system. The new PET/CT system will enhance preclinical imaging research capabilities at the Yale PET Center, enabling improved spatial localization of radiopharmaceutical probes, image-based measurement of tracer input function, and...
The National Institute of Neurological Disorders and Stroke (NINDS) awarded a $235,887 Project Grant (93.853 - Extramural Research Programs in the Neurosciences and Neurological Disorders) to The Research Foundation For The State University Of New York, doing business as Stony Brook University. This 2-year grant, effective from April 1, 2025 to March 31, 2027, will support the development of a chemical strategy to enable light microscopy-based imaging of neural synapses and circuit...
This Project Grant award of $621,500 from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, supports the development of innovative methods for combined molecular and ultrastructural imaging of neural cells and tissues. The key products and services being delivered through this 5-year award, which began on December 11, 2024, include: Developing detergent-free...
This $234,949 federal Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) supports research at Yale University to investigate the capacity and necessity of intact and lesioned supraspinal raphespinal tract terminals in supporting rehabilitation-induced functional recovery after spinal cord injury. The research will leverage anatomy, spatial...
The National Institute of Neurological Disorders and Stroke (NINDS) awarded a $135,000 Project Grant under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) to the University of Rochester. The grant, titled "The NeuroCity Initiative: Empowering Underrepresented Scholars to Pursue Careers in Neuroscience," provides an immersive research and mentoring experience, a rigorous career development program, and continuous research and mentoring...
The National Institute of Biomedical Imaging and Bioengineering awarded a $1,372,638 Project Grant (CFDA 93.286 - Discovery and Applied Research for Technological Innovations to Improve Human Health) to Yale University to develop hardware and software innovations to enable the parallel acquisition of high-quality Deuterium Metabolic Imaging (DMI) and standard MRI brain scans. The project aims to integrate DMI, a novel non-invasive metabolic imaging technique, into a standard clinical brain...
This $297,554 Project Grant award, provided by the National Institute of Neurological Disorders and Stroke (NINDS) through the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, supports the development of a training program in neurophotonics at Trustees of Boston University. The program aims to produce the next generation of investigators capable of rigorously applying photonics methods across neuroscience sub-fields to advance understanding...
This federal Project Grant award, worth $694,369, was provided by the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program. The award supports a multi-scale, multi-modal imaging study to examine the association between cognitive decline and changes in brain structure, function, and neuronal integrity in patients with multiple sclerosis (MS). The primary awardee, Weill...
This federal Project Grant award, valued at $516,944 and provided by the National Institute of Biomedical Imaging and Bioengineering (CFDA 93.286 - Discovery and Applied Research for Technological Innovations to Improve Human Health), will develop a novel molecular imaging technology that combines Positron Emission Tomography (PET) and Ultrasound (US) imaging. The goal is to enable interactive PET and US scanning with real-time visualization of molecular contrast fused with US images to...

This $244,500 Project Grant was awarded by the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) federal grant program. The grant funds the development of a new computational technology for processing PET/SPECT neuroimaging data using projective geometry techniques. This methodology aims to enable reference-region-free analysis of PET/SPECT images, expanding the utility of tracers that lack an optimal reference region. The research has three key objectives: 1) fully developing the mathematical and algorithmic foundations of the projective approach, 2) evaluating the method using a dataset of the SPECT tracer ioflupane, and 3) assessing performance with a new PET tracer for the synaptic vesicle protein SV2A. The award was made to Yale University, a private research university in Connecticut, and the grant period runs from April 1, 2025 to March 31, 2027.

Generated 4/8/25, 3:10 AM